Methylation‐regulated expression of cancer testis antigens in primary effusion lymphoma: Immunotherapeutic implications
- 5 August 2004
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 202 (2) , 474-477
Abstract
Primary effusion lymphoma (PEL) is a large B‐cell neoplasm with an unfavorable prognosis and limited therapeutic options. In this study, cancer testis antigens (CTA) were investigated as potential immunotherapeutic targets in patients with PEL. Baseline expression of a panel of 11 CTA was highly heterogeneous among five PEL cell lines. In particular, the investigated CTA were not expressed in BC‐2 and BC‐3 cells, while BC‐1, HBL‐6, and BCBL‐1 cells tested positive for 6, 8, and 9 CTA, respectively. The DNA hypomethylating agent 5‐aza‐2′‐deoxycytdine (5‐AZA‐CdR) invariably induced or up‐regulated the expression of all investigated CTA in all cell lines analyzed. The de novo expression of CTA was still detectable at mRNA and protein level at least 2 months after the end of 5‐AZA‐CdR treatment. These findings, and the concomitant up‐regulation of HLA‐class I antigens and ICAM‐1 by 5‐AZA‐CdR, support its clinical use to set‐up innovative chemo‐immunotherapeutic approaches in PEL.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (AIRC)
- Progetto Ricerca Finalizzata awarded by the Italian Ministry of Public Health
This publication has 21 references indexed in Scilit:
- Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignanciesBlood, 2004
- Epigenetic targets for immune intervention in human malignanciesOncogene, 2003
- 5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach?Blood, 2003
- Cancer/testis‐associated genes: Identification, expression profile, and putative functionJournal of Cellular Physiology, 2003
- CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysisInternational Journal of Cancer, 2000
- Quantitative evaluation of the expression ofMAGE genes in tumors by limiting dilution of cDNA librariesInternational Journal of Cancer, 1999
- Prolonged Upregulation of the Expression of HLA Class I Antigens and Co stimulatory Molecules on Melanoma Cells Treated with 5-aza-2??-deoxycytidine (5-AZA-CdR)Journal of Immunotherapy, 1999
- Expression of MAGE genes in primary and metastatic cutaneous melanomaInternational Journal of Cancer, 1995
- A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.Journal of Experimental Medicine, 1995
- Purification of Murine IgG Monoclonal Antibodies by Precipitation with Caprylic Acid: Comparison with Other Methods of PurificationHybridoma, 1989